Interaction Checker

Interacciones de Aztreonam

Aztreonam (Azactam, Cayston), antibiótico, tiene 46 interacciones documentadas en las etiquetas de la FDA y las hojas informativas que indexamos. Graves: 0; moderadas: 46; leves: 0; casos en los que una etiqueta indica que no hay ninguna interacción significativa: 0. Cada entrada de abajo cita la frase que la respalda. Esta página del medicamento es un punto de partida, no un veredicto sobre su situación.

Interacciones según la etiqueta

Interacciones moderadas (46)

  • AclidinioanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • AdrenalinasimpaticomiméticoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • AminofilinametilxantinaModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Amoxicilinaantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Amoxicilina y ácido clavulánicoantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Ampicilinaantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Ampicilina y sulbactamantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Arformoterolagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Budesonida y formoterolcorticosteroideModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefaclorcefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefadroxilocefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefalexinacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefazolinacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefdinircefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefepimacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefiximacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefotaximacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefotetáncefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefoxitinacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefpodoximacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefprozilocefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CeftarolinacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CeftazidimacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CeftriaxonacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • CefuroximacefalosporinaModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Dicloxacilinaantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Fluticasona y salmeterolcorticosteroideModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Formoterolagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • IpratropioanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Ipratropio y salbutamolanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Isoprenalina (isoproterenol)agonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Levosalbutamolagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Mirabegrónagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Nafcilinaantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Oxacilinaantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Penicilina Gantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Penicilina Vantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Piperacilina y tazobactamantibiótico del grupo de las penicilinasModerada

    Use caution when CAYSTON is administered to patients with a known allergic reaction to beta-lactams. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Salbutamolagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Salmeterolagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • TeofilinametilxantinaModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Terbutalinaagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • TiotropioanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • UmeclidinioanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Umeclidinio y vilanterolanticolinérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

  • Vibegrónagonista beta-adrenérgicoModerada

    Reduction of 15% or more in forced expiratory volume in 1 second (FEV 1 ) immediately following administration of study medication after pretreatment with a bronchodilator was observed in 3% of patients treated with CAYSTON. (etiqueta de Aztreonam, Advertencias y precauciones)

Compruebe Aztreonam frente a todo lo que toma. Añada su lista completa; todos los pares se comprueban a la vez.

Abrir en el verificador

No es un consejo médico. La gravedad refleja la redacción de la etiqueta, no sus circunstancias. Una señal «grave» puede ser algo habitual bajo supervisión y una «leve» puede ser importante a dosis altas. Consulte a un farmacéutico.